Journal
STEM CELL RESEARCH
Volume 53, Issue -, Pages -Publisher
ELSEVIER
DOI: 10.1016/j.scr.2021.102276
Keywords
-
Funding
- LouLou Foundation
- Massachusetts Life Sciences Center
- Intellectual and Developmental Disabilities Research Center [NIH-NICHD U54HD090255]
Ask authors/readers for more resources
This report documents the generation and characterization of induced pluripotent stem cells (iPSCs) derived from fibroblasts of six unrelated CDD patients, including three males and three females, who are clinically diagnosed with classic CDD phenotypes such as refractory epilepsy and global developmental delay. These patients are part of a longitudinal clinical study.
CDKL5 Deficiency Disorder (CDD) is a rare X-linked monogenic developmental encephalopathy that is estimated to affect 1:42,000 live births. CDD is caused by pathogenic variants in the CDKL5 gene and is observed in both male and female patients. Here, we report the generation and characterization of induced pluripotent stem cells (iPSCs) derived from fibroblasts of six unrelated CDD patients-three males and three females. These patients are clinically diagnosed to present with classic CDD phenotypes, including refractory epilepsy and global developmental delay, and are being followed in a longitudinal clinical study.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available